Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.

Endokrynologia Polska - 1 Jan 2017

Fekih Ons, Triki Sonia, Rejeb Jihene, Neffati Fadoua, Douki Wahiba, Ommezzine Asma, Chouchane Slaheddine, Guediche Mohamed Neji, Bouslama Ali, Najjar Mohamed Fadhel

Abstract excerpt

INTRODUCTION: Paraoxonase 1 (PON1) polymorphisms have been largely involved in diabetes complications. The aim of the study is to evaluate the effects of PON1 polymorphisms (L55M and Q192R) on diabetic nephropathy (DN). MATERIAL AND METHODS: The study involved 116 children and adolescents with type 1 diabetes (T1D) and 91 healthy subjects. Albumin excretion rate (AER) was determined by immunoturbidimetry. PON1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryldialkylphosphatase
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Diabetic Nephropathies

Share to Genetic Association Studies

Share to Haplotypes

Share to Infant

Share to Young Adult

Source

Identifiers

PMID: 26884296
DOI: 10.5603/EP.a2016.0027

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.PMID 26884296Read ↗

Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?Semantic proximity Read ↗

Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.Semantic proximity Read ↗

Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes.Semantic proximity Read ↗

The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients.Semantic proximity Read ↗

Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.Semantic proximity Read ↗

Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.Semantic proximity Read ↗

Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy.Semantic proximity Read ↗

Association of paraoxonase-1 gene polymorphisms with insulin resistance in South Indian population.Semantic proximity Read ↗

Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.Semantic proximity Read ↗

European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.Semantic proximity Read ↗

Association between PON 1 polymorphisms, PON activity and diabetes complications.Semantic proximity Read ↗

Enzyme Activity and Genetic Polymorphisms of Paraoxonase 1 in Patients With Type 2 Diabetes Mellitus: A Case-Control StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.